Quantcast

Latest Melanoma Stories

2014-05-20 12:33:11

Convenes Policymaker Event, Highlights New Research, Organizes Social Media Push WASHINGTON, May 20, 2014 /PRNewswire/ -- In recognition that May is Skin Cancer Awareness Month, L'Oreal USA and the Public Access to SunScreens (PASS) Coalition sponsored a policy breakfast today focused on new innovations in sunscreen and legislation to establish a regulatory pathway for timely pre-market review of new, safe and effective over-the-counter sunscreen ingredients. The breakfast, which...

2014-05-15 08:32:30

First Case Study Announced While Broader Data Being Collected; Evidence Indicates Substantial Tumor Necrosis and Initial Tumor Regression BETHESDA, Md., May 15, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today provided an initial patient case study, showing signs of tumor necrosis (tumor death) and initial tumor regression, from the Company's ongoing...

2014-05-14 16:29:17

DecisionDx-Melanoma identifies patients with negative sentinel lymph node biopsies who are at high risk of metastasis FRIENDSWOOD, Texas, May 14, 2014 /PRNewswire/ -- Castle Biosciences Inc. announced today that abstracts reporting additional clinical validation data for two of its molecular tests -- one focused on melanoma and the other on esophageal adenocarcinoma -- will be presented at the 50(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30-June 3,...

2014-05-14 08:30:37

BOULDER, Colo., May 14, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, binimetinib (MEK162) (co-developing with Novartis) and selumetinib (licensed to AstraZeneca) at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 30 - June 3, 2014 in Chicago, Illinois. Both MEK inhibitors are advancing in Phase 3 or pivotal trials: binimetinib is being evaluated in NRAS- and BRAF-mutant...

2014-05-13 23:09:20

Skin Cancer Awareness Month provides opportunities for dermatologists like Dr. Mitchel Goldman of Cosmetic Laser Dermatology to encourage patients to practice healthy skin care habits in order to prevent skin cancer. San Diego, CA (PRWEB) May 13, 2014 In a recent news segment, Dr. Mitchel Goldman, board-certified dermatologist and President of the American Society for Dermatologic Surgery (representing over 5,800 dermatologists in the USA), discussed the important facts surrounding Skin...

2014-05-13 08:31:13

NEW YORK, May 13, 2014 /PRNewswire/ -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) is a development stage biopharmaceutical company that is primarily engaged in developing oncology and dermatology therapies through its two predominant drug candidates, PV-10 and PH-10. The company is working to develop PV-10 for the treatment of several life-threatening cancers, including metastatic melanoma, liver cancer (also known as Hepatocellular carcinoma, or HCC), and breast cancer....

2014-05-12 23:11:19

In the heat of Skin Cancer Awareness month, Goddess Garden Organics and 16 other mineral sunscreen companies have partnered with the Environmental Working Group (EWG) to launch a Sun Safety Campaign to raise awareness about dangers of sun exposure and promote alternatives that allow the public to enjoy the sun safely. Boulder, CO (PRWEB) May 12, 2014 Goddess Garden is one of seventeen sunscreen brands that have banded together to support the Environmental Working Group (EWG) and its...

What Leads To Cancer Formation In Melanoma?
2014-05-09 03:19:54

Oregon State University Researchers at Oregon State University have identified a specific biochemical process that can cause normal and healthy skin cells to transform into cancerous melanoma cells, which should help predict melanoma vulnerability and could also lead to future therapies. More than 70,000 cases of melanoma, the deadliest form of skin cancer, develop in the U.S. every year. The work was published today in PLoS Genetics, in work supported by the National Institutes of...

2014-05-08 23:05:37

“Education obtained at the dermatology appointment may improve early self-detection of melanoma, and having an established dermatologist may facilitate earlier evaluation of concerning lesions,” according to a recent study in The Journal of the American Academy of Dermatology. (PRWEB) May 08, 2014 Early-stage melanoma is more detectable on patients that visit a knowledgeable, board certified dermatologist on a regular basis than those who forego consistent checkups, according to a...

2014-05-07 23:13:47

One of Sevique’s bestselling products is Dawn til Dark, an all-in-one anti-aging moisturizer with SPF 35 protection from harmful UVA/UVB rays. Its light weight texture makes it a great make primer and easy to apply on the go. (PRWEB) May 07, 2014 May is Skin Cancer Awareness Month and with the number of new cases increasing substantially each year (it is estimated there will be 140,000 new cases of melanoma in 2014 and approximately 1 in 5 Americans will develop skin cancer in their...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related